Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)
China
· Delayed Price · Currency is CNY 11.34
-0.36 (-3.08%)
Feb 28, 2025, 2:45 PM CST
SHE:002399 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 27, 2025 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 15,052 | 15,345 | 17,090 | 22,787 | 23,671 | 24,333 | Upgrade
|
| Market Cap Growth | -7.03% | -10.21% | -25.00% | -3.74% | -2.72% | -15.36% | Upgrade
|
| Enterprise Value | 16,357 | 19,083 | 19,992 | 24,281 | 25,891 | 29,113 | Upgrade
|
| Last Close Price | 11.33 | 11.73 | 12.74 | 16.91 | 16.87 | 18.98 | Upgrade
|
| PE Ratio | - | - | 23.49 | 94.63 | 23.11 | 22.97 | Upgrade
|
| Forward PE | 22.55 | 22.53 | 22.53 | 22.53 | 22.53 | 22.53 | Upgrade
|
| PS Ratio | 3.05 | 2.82 | 2.39 | 3.58 | 4.44 | 5.26 | Upgrade
|
| PB Ratio | 1.37 | 1.28 | 1.38 | 1.98 | 2.03 | 3.26 | Upgrade
|
| P/TBV Ratio | 1.60 | 1.68 | 1.81 | 2.62 | 2.70 | 5.63 | Upgrade
|
| P/FCF Ratio | 7.86 | - | - | - | - | - | Upgrade
|
| P/OCF Ratio | 6.20 | 38.53 | - | - | 634.89 | - | Upgrade
|
| EV/Sales Ratio | 3.00 | 3.50 | 2.79 | 3.81 | 4.86 | 6.30 | Upgrade
|
| EV/EBITDA Ratio | 54.41 | 223.24 | 15.71 | 22.00 | 20.11 | 29.04 | Upgrade
|
| EV/EBIT Ratio | - | - | 20.02 | 29.13 | 25.54 | 38.98 | Upgrade
|
| EV/FCF Ratio | 7.74 | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.35 | 0.46 | 0.52 | 0.49 | 0.48 | 0.84 | Upgrade
|
| Debt / EBITDA Ratio | 14.34 | 46.80 | 4.95 | 4.98 | 4.28 | 6.28 | Upgrade
|
| Debt / FCF Ratio | 2.04 | - | - | - | - | - | Upgrade
|
| Asset Turnover | 0.29 | 0.27 | 0.36 | 0.33 | 0.31 | 0.32 | Upgrade
|
| Inventory Turnover | 0.67 | 0.67 | 0.84 | 1.11 | 1.19 | 1.46 | Upgrade
|
| Quick Ratio | 1.01 | 0.73 | 0.93 | 1.19 | 1.52 | 0.62 | Upgrade
|
| Current Ratio | 2.39 | 2.13 | 2.22 | 2.25 | 2.53 | 1.21 | Upgrade
|
| Return on Equity (ROE) | -1.34% | -6.58% | 5.98% | 2.01% | 10.66% | 15.30% | Upgrade
|
| Return on Assets (ROA) | -0.31% | -0.74% | 3.13% | 2.73% | 3.70% | 3.24% | Upgrade
|
| Return on Capital (ROIC) | -0.34% | -0.82% | 3.46% | 3.02% | 4.07% | 3.76% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 6.55% | 5.82% | 6.58% | 7.27% | Upgrade
|
| Earnings Yield | -0.97% | -5.10% | 4.26% | 1.06% | 4.33% | 4.35% | Upgrade
|
| FCF Yield | 14.04% | -0.30% | -5.73% | -0.88% | -0.74% | -2.42% | Upgrade
|
| Dividend Yield | 0.00% | - | 0.79% | 0.21% | 0.89% | 0.95% | Upgrade
|
| Payout Ratio | 0.00% | - | 34.51% | 171.31% | 43.69% | 32.33% | Upgrade
|
| Buyback Yield / Dilution | 0.01% | 0.05% | -0.05% | -8.42% | -8.51% | 0.01% | Upgrade
|
| Total Shareholder Return | 0.01% | 0.05% | 0.73% | -8.22% | -7.62% | 0.96% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.